1
Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
2
Chronic Respiratory Disease Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract
Despite the fact that about two years have passed since the onset of the COVID-19 pandemic, there is still no curative treatment for the disease. Most cases of COVID-19 have mild or moderate illness and do not require hospitalization.
This guideline released by the National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Masih Daneshvari Hospital COVID-19 Expert Group to provide a treatment guide for outpatient management of COVID-19.
Rezaei,M , Jamaati,H , Tabarsi,P , Moniri,A , Marjani,M and Velayati,A A . (2021). NRITLD Protocol for the Management of Outpatient Cases of COVID-19. TANAFFOS (Respiration), 20(3), 192-196.
MLA
Rezaei,M , , Jamaati,H , , Tabarsi,P , , Moniri,A , , Marjani,M , and Velayati,A A . "NRITLD Protocol for the Management of Outpatient Cases of COVID-19", TANAFFOS (Respiration), 20, 3, 2021, 192-196.
HARVARD
Rezaei M, Jamaati H, Tabarsi P, Moniri A, Marjani M, Velayati A A. (2021). 'NRITLD Protocol for the Management of Outpatient Cases of COVID-19', TANAFFOS (Respiration), 20(3), pp. 192-196.
CHICAGO
M Rezaei, H Jamaati, P Tabarsi, A Moniri, M Marjani and A A Velayati, "NRITLD Protocol for the Management of Outpatient Cases of COVID-19," TANAFFOS (Respiration), 20 3 (2021): 192-196,
VANCOUVER
Rezaei M, Jamaati H, Tabarsi P, Moniri A, Marjani M, Velayati A A. NRITLD Protocol for the Management of Outpatient Cases of COVID-19. TANAFFOS (Respiration). 2021;20(3):192-196.
